MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-RJ-17-0172602
Savioris Pharmaceuticals Private Limited
Savioris Pharmaceuticals Private Limited - chemicals in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.17 Lakh
▲ 42% YoY
Net profit · FY 2025
₹7,031
Net margin 0.6%
EBITDA · FY 2025
₹11,405
EBITDA margin 0.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Savioris Pharmaceuticals Private Limited
Data last updated:
Savioris Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 29 June 2022.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24290RJ2022PTC082299. Its GSTIN is 08ABICS8552M1ZK (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Fatma Bano and Ashraf Kathat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P. No. A – 36 F. No. S – 2 A.R. Villa Radha Vihar New Sanganer Road, Jaipur, Rajasthan, India – 302019.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.17 Lakh, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹7,031 (net margin 0.6%) and EBITDA of ₹11,405 (EBITDA margin 0.9%).
Savioris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0172602).
Company Details of Savioris Pharmaceuticals Private Limited
CIN U24290RJ2022PTC082299
Registration Number 082299
Incorporation Date 29 June 2022
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0172602
Key People
Fatma Bano Director Ashraf Kathat Director Recognitions & Rankings of Savioris Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressP. No. A – 36 F. No. S – 2 A.R. Villa Radha Vihar New Sanganer Road, Jaipur, Rajasthan, India – 302019
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
Comprehensive company report
Savioris Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Savioris Pharmaceuticals Private Limited
The main business activity of Savioris Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Savioris Pharmaceuticals Private Limited FY 2025 filings available
Savioris Pharmaceuticals Private Limited reported revenue of ₹12.17 Lakh (up 42% YoY) for FY 2025.
Revenue · FY 2025
₹12.17 Lakh ▲ 42%
Net profit · FY 2025
₹7,031 margin 0.6%
EBITDA · FY 2025
₹11,405 margin 0.9%
Compounded Annual Growth Rate (CAGR) of Savioris Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 42%
EBITDA CAGR growth
1 year
▼ 70%
Revenue rose 42% in the latest year. EBITDA fell 70% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Savioris Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹11,405 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7,031 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Savioris Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.9% | •••• | •••• |
| Net Profit Margin | 0.6% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Savioris Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Savioris Pharmaceuticals Private Limited
Savioris Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Fatma Bano | Director | 29 Jun 2022 | 4 Years 3 Months | Current |
| Ashraf Kathat | Director | 29 Jun 2022 | 4 Years 3 Months | Current |
Peer Comparison of Savioris Pharmaceuticals Private Limited
Savioris Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Awwa Pharmaceuticals Private Limited | ₹12.24 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Navi Mumbai, Maharashtra, India |
| Deltacure Pharmaceuticals Private Limited | ₹12.21 Lakh (FY 2025) | •••• | •••• | 26.0% | •••• | Jehanabad, Bihar, India |
| Moseley Pharmaceuticals Private Limited | ₹12.2 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Lucknow, Uttar Pradesh, India |
| Riddhi Pharmaceuticals Limited | ₹12.2 Lakh (FY 2025) | •••• | •••• | 460139.0% | •••• | Mumbai, Maharashtra, India |
| Cocoon Pharmaceuticals Private Limited | ₹12.18 Lakh (FY 2022) | •••• | •••• | •••• | Titwala, Maharashtra, India | |
| Savioris Pharmaceuticals Private Limited this company | ₹12.17 Lakh (FY 2025) | •••• | •••• | 42.0% | •••• | Jaipur, Rajasthan, India |
| Kotac Pharmaceuticals Private Limited | ₹12.17 Lakh (FY 2024) | •••• | •••• | -58.0% | •••• | Budaun, Uttar Pradesh, India |
| Bexley Pharmaceuticals Private Limited | ₹12.16 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Rimax Pharmaceuticals Private Limited | ₹12.11 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Siddson Pharmaceuticals Private Limited | ₹12.11 Lakh (FY 2025) | •••• | •••• | •••• | Belgaum, Karnataka, India | |
| Dossier Pharmaceuticals Private Limited | ₹12.07 Lakh (FY 2018) | •••• | •••• | 108.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Savioris Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Savioris Pharmaceuticals Private Limited
Savioris Pharmaceuticals Private Limited is audited by TIBREWAL CHAND & CO. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| TIBREWAL CHAND & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Savioris Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Savioris Pharmaceuticals Private Limited
Savioris Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Savioris Pharmaceuticals Private Limited
Savioris Pharmaceuticals Private Limited has a workforce of 0 employees as of Mar 25, 2025.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Savioris Pharmaceuticals Private Limited
Savioris Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Ashraf Kathat was appointed as Director on 29 Jun 2022.
AGM
Savioris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Savioris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Appointed
Ashraf Kathat was appointed as Director.
Appointed
Fatma Bano was appointed as Director.
Incorporation
29 Jun 2022
Savioris Pharmaceuticals Private Limited was registered on 29 Jun 2022 with Roc Jaipur & aged 4 years 3 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Savioris Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Savioris Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Savioris Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Savioris Pharmaceuticals Private Limited
Savioris Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08ABICS8552M1ZK | Rajasthan | Active | 02 Aug 2022 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Savioris Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Savioris Pharmaceuticals Private Limited
Savioris Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in chemical products, within the chemicals industry. It was incorporated on 29 June 2022 (4+ years old) and is registered under CIN U24290RJ2022PTC082299.
Savioris Pharmaceuticals reported revenue of ₹12.17 Lakh for FY 2025 (up 42% YoY).
Savioris Pharmaceuticals has 2 current directors:
- Fatma Bano - Director
- Ashraf Kathat - Director
Savioris Pharmaceuticals reported a net profit of ₹7,031 (net margin 0.6%) and EBITDA of ₹11,405 (EBITDA margin 0.9%) for FY 2025, as per its filed financial statements.
The GSTIN of Savioris Pharmaceuticals is 08ABICS8552M1ZK, registered in Rajasthan.
The CIN (Corporate Identification Number) of Savioris Pharmaceuticals is U24290RJ2022PTC082299. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Savioris Pharmaceuticals was incorporated on 29 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Savioris Pharmaceuticals by revenue are Awwa Pharmaceuticals Private Limited, Deltacure Pharmaceuticals Private Limited, Moseley Pharmaceuticals Private Limited, Riddhi Pharmaceuticals Limited, Cocoon Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ashraf Kathat was appointed as Director on 29 Jun 2022. Fatma Bano was appointed as Director on 29 Jun 2022.
Yes, Savioris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0172602).
The registered office of Savioris Pharmaceuticals is at P. No. A – 36 F. No. S – 2 A.R. Villa Radha Vihar New Sanganer Road, Jaipur, Rajasthan, India – 302019.